340B PATIENTS Act of 2025

This bill aims to protect patients’ access to lower-cost drugs under the 340B program. It makes clear that drug makers must honor 340B discount prices no matter how or where a medicine is dispensed—at a hospital or clinic, through a local contract pharmacy, by mail, or at a specialty pharmacy. It also says manufacturers cannot add new hurdles, like limiting where drugs can be delivered or demanding extra claims data, unless those conditions are standard business practice and approved in advance by federal health officials .

Hospitals, clinics, and health centers in 340B can keep using one or more contract pharmacies to get medicines to their patients, and all 340B protections still apply in those cases. If a manufacturer intentionally breaks these rules (other than overcharging), the government can fine them up to $2,000,000 per day until they fix the problem. The health department must set detailed rules for these penalties and create a way for 340B providers to file claims within 180 days of the bill becoming law .

Key points

• Who is affected: Patients and 340B providers (hospitals, clinics, and health centers), contract pharmacies, and drug manufacturers.
• What changes: Manufacturers must honor 340B prices regardless of how/where drugs are dispensed; they are blocked from adding restrictions that limit access; strong daily fines for intentional violations; providers can bring claims under a new process .
• When: The health department must issue regulations within 180 days to define penalties and the claims process.